## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.8% in upper entry zone (3.0-6.0%), top 2% cross-sectional ranking. Short-term MRS_5 (3.3%) confirms momentum alignment. Outperforming sector by 3.9%. Caution: overbought RSI (81).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($48.93)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 9)

**1. Levi & Korsinsky Reminds Freeport-McMoRan Inc. Investors of**
- Source: GlobeNewswire | 20251223T212959 | Somewhat-Bearish | Relevance: 100%
- Levi & Korsinsky, LLP is reminding investors in Freeport-McMoRan Inc. (NYSE: FCX) of a class action securities lawsuit. The lawsuit alleges that Freeport-McMoRan made false statements and/or concealed inadequate safety measures at its Grasberg Block Cave mine, leading to heightened risks for workers. Investors who suffered losses between February 15, 2022, and September 24, 2025, have until January 12, 2026, to request to be appointed as lead plaintiff.

**2. SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Announces that Freeport-McMoran Systems Investors Have Opportunity to Lead Class Action Lawsuit**
- Source: Morningstar | 20251223T160753 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is reminding Freeport-McMoran investors of an upcoming deadline to lead a federal securities class action lawsuit. The lawsuit alleges that Freeport-McMoran made false and misleading statements and failed to disclose safety issues at its Grasberg Block Cave mine in Indonesia, which led to worker deaths and significant stock price drops. Investors who suffered losses between February 15, 2022, and September 24, 2025, are encouraged to contact the firm to discuss their legal options.

**3. Freeport-McMoRan Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 12, 2026 to Discuss Your Rights - FCX**
- Source: Morningstar | 20251223T140737 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a class action securities lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) alleging securities fraud between February 15, 2022, and September 24, 2025. The lawsuit claims the company made false statements and concealed inadequate safety at the Grasberg Block Cave mine, leading to heightened risks. Investors who suffered losses have until January 12, 2026, to request to be appointed as lead plaintiff.

**4. Freeport-McMoRan Inc. (FCX) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of January 12, 2026 Deadline**
- Source: FOX40 News | 20251222T230855 | Bearish | Relevance: 100%
- Levi & Korsinsky, LLP has filed a securities class action lawsuit against Freeport-McMoRan Inc. (NYSE:FCX) on behalf of investors who suffered losses due to alleged securities fraud between February 15, 2022, and September 24, 2025. The lawsuit claims that Freeport-McMoRan made false statements and/or concealed inadequate safety measures at its Grasberg Block Cave mine in Indonesia, leading to heightened regulatory, litigation, and reputational risks. Investors are reminded of the January 12, 2026 deadline to explore potential recovery under federal securities laws.

**5. Shareholders that lost money on Freeport-McMoRan Inc.(FCX) should contact The Gross Law Firm about pending Class Action - FCX**
- Source: FOX40 News | 20251222T210855 | Bearish | Relevance: 100%
- The Gross Law Firm has issued a notice to shareholders of Freeport-McMoRan Inc. (NYSE: FCX) regarding a pending class action lawsuit. The complaint alleges that Freeport-McMoRan did not adequately ensure safety at its Grasberg Block Cave mine, leading to heightened risks for workers and potential regulatory, litigation, and reputational damage. Shareholders who purchased FCX shares between February 15, 2022, and September 24, 2025, are encouraged to contact the firm by the January 12, 2026, deadline to seek lead plaintiff appointment.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | Wells Fargo | $55 | $47 | +17% |
| 2025-12-12 | UBS | $60 | $55 | +9% |
| 2025-12-05 | JP Morgan | $58 | $50 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | Wells Fargo | main | Overweight |
| 2025-12-12 | UBS | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.2x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +14%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.19 signals overvaluation risk, limited margin of safety. Forward P/E 23.0x attractive for 48% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment positive (3 raises, avg +14%). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $74.5B |
| Beta | 1.48 |
| 52W Range | $27.66 - $52.29 |
| Short Interest | 1.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.19 |
| Forward P/E | 23.0 |
| Current P/E | 33.9 |
| YoY Growth | 47.7% |
| EPS Direction | FALLING |

### Technicals

MRS_10 stable at 5.8% (minimal 5-day change). Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 98th percentile. MRS_5 at 3.3% confirms short-term momentum alignment. Outperforming sector by 3.9pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 81, risk of mean reversion. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.77% (CS: 98) | Strong |
| RSI_14 | 81.1 | Overbought |
| MACD Histogram | 0.50 | Bullish |
| vs SMA20 | 1.127x | Above |
| vs SMA50 | 1.209x | Above |
| vs SMA200 | 1.260x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $51.91
- **Stop Loss:** $48.93 (5.7% risk)
- **Target:** $56.38 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 302
- **Position Value:** $15,676.82
- **Portfolio %:** 15.68%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*